ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,371 | +6.0% | 3,731 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $329,511 | -22.2% | 3,692 | -6.5% | 0.00% | 0.0% |
| Q1 2023 | $423,305 | -25.0% | 3,948 | -14.5% | 0.00% | -50.0% |
| Q4 2022 | $564,118 | +17.0% | 4,619 | -1.0% | 0.00% | 0.0% |
| Q3 2022 | $482,000 | +19.9% | 4,667 | +8.0% | 0.00% | +100.0% |
| Q2 2022 | $402,000 | -40.3% | 4,320 | -24.7% | 0.00% | 0.0% |
| Q1 2022 | $673,000 | -35.8% | 5,738 | -26.3% | 0.00% | -50.0% |
| Q4 2021 | $1,048,000 | -41.2% | 7,789 | -30.3% | 0.00% | -60.0% |
| Q3 2021 | $1,782,000 | +44.3% | 11,178 | +19.1% | 0.01% | +25.0% |
| Q2 2021 | $1,235,000 | +32.8% | 9,388 | +30.0% | 0.00% | +33.3% |
| Q1 2021 | $930,000 | -30.2% | 7,219 | -9.7% | 0.00% | -40.0% |
| Q4 2020 | $1,333,000 | +14.7% | 7,994 | +6.2% | 0.01% | 0.0% |
| Q3 2020 | $1,162,000 | +6.5% | 7,530 | +2.1% | 0.01% | -16.7% |
| Q2 2020 | $1,091,000 | +53.4% | 7,376 | +16.8% | 0.01% | +20.0% |
| Q1 2020 | $711,000 | -48.4% | 6,317 | -36.3% | 0.01% | -16.7% |
| Q4 2019 | $1,379,000 | +15.8% | 9,912 | -19.8% | 0.01% | -14.3% |
| Q3 2019 | $1,191,000 | -21.3% | 12,365 | -6.0% | 0.01% | -22.2% |
| Q2 2019 | $1,514,000 | -6.0% | 13,152 | -3.9% | 0.01% | -10.0% |
| Q1 2019 | $1,611,000 | +91.1% | 13,684 | +1.8% | 0.01% | +66.7% |
| Q4 2018 | $843,000 | -26.1% | 13,448 | -16.5% | 0.01% | -25.0% |
| Q3 2018 | $1,141,000 | +8.3% | 16,104 | +1.7% | 0.01% | +14.3% |
| Q2 2018 | $1,054,000 | +6.8% | 15,840 | +5.0% | 0.01% | +16.7% |
| Q1 2018 | $987,000 | +42.8% | 15,090 | -12.5% | 0.01% | +20.0% |
| Q4 2017 | $691,000 | – | 17,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |